Lymph Node Metastases Clinical Trial
Official title:
To Accurately Assess Lymph Node Response to Neoadjuvant Chemotherapy by Wire Localization of Clip-marked Axillary Lymph Nodes in Breast Cancer Patients
The investigator developed this protocol to accurately assess lymph node response to neoadjuvant chemotherapy in clinical stage N1 (cN1) breast cancer patients. Accuracy of sentinel lymph node biopsy (SLNB) alone and in combination with the removal of wire-localized-clip-marked nodes will be analyzed. New model to predict lymph node pathological complete remission (pCR) so as to safely avoid axillary lymph node dissection in cN1 breast cancer patients is sought for.
The investigator developed this protocol to accurately assess lymph node response to neoadjuvant chemotherapy in cN1 breast cancer patients. In brief, pathologically proven positive axillary lymph node will be clip-marked before the initiation of neoadjuvant chemotherapy (NACT) and continuously monitored through out the course of chemotherapy with ultrasound. After the completion of neoadjuvant chemotherapy, a wire will be placed to localize the clip-marked node before surgery. During surgery, a standard sentinel lymph node biopsy will be performed as well as the removal of the wire localized node. Axillary lymph node dissection (ALND) will be performed in all participants. Accuracy of SLNB alone and in combination with the removal of wire-localized-clip-marked nodes will be analyzed. Axillary ultrasound and CT scan will be performed before and after neoadjuvant chemotherapy for all patients enrolled. By assessing clinical-pathological and imaging data acquired from this trial, the investigator look forward to developing a model to accurately predict lymph node pCR (AUC >0.85) so as to safely avoid axillary lymph node dissection in cN1 breast cancer patients. ;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03280719 -
Whole Breast + Lymph Node Irradiation: Prone Compared to Supine Position in 15 or 5 Fractions
|
N/A | |
Active, not recruiting |
NCT04300673 -
Radio Guided Lymph Node Dissection in Oligometastatic Prostate Cancer Patients
|
Phase 1/Phase 2 | |
Completed |
NCT04260139 -
Lymph Node Yield in Colon Cancer Resection Specimens
|
||
Not yet recruiting |
NCT03632746 -
Verifying the Specificity of a New Method in Predicting Lymph Node Metastasis in Early Gastric Cancer Patients
|
||
Active, not recruiting |
NCT03776591 -
Open D3 Right Hemicolectomy Compared to Laparoscopic CME for Right Sided Colon Cancer
|
N/A | |
Recruiting |
NCT05078853 -
Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma
|
||
Recruiting |
NCT03280134 -
A Prospective Validation Cohort Study of a Prediction System on nSLN Metastasis in Early Breast Cancer
|
N/A | |
Recruiting |
NCT04117139 -
The Diagnostic Value of PET/MRI in Head and Neck Cancer
|
N/A | |
Recruiting |
NCT04882618 -
Use of Indocyanine Green During Pelvic Lymph Node Dissection in Prostate Cancer.
|
Phase 4 | |
Recruiting |
NCT05670574 -
Surgery With Extended (D3) Mesenterectomy for Small Bowel Tumors
|
N/A | |
Active, not recruiting |
NCT04611997 -
IGG Using in Laparoscopic Gastrectomy for Locally Advanced Gastric Cancer After Neoadjuvant Chemotherapy
|
Phase 3 | |
Recruiting |
NCT04744506 -
Targeted Resection of Axillary Metastatic Lymph Nodes After Breast Cancer Neoadjuvant Chemotherapy
|
N/A | |
Recruiting |
NCT03830242 -
Diagnostic Significance of FDG PET/CT Dynamic Imaging in Detecting Metastatic Lymph Nodes With Papillary Thyroid Cancer.
|
N/A | |
Recruiting |
NCT04959604 -
Lymph Node Mapping Via Flourescent Dye in Colon Cancer
|
N/A | |
Active, not recruiting |
NCT04419935 -
Lymphadenectomy in NSCLC With and Without Adjuvant Therapy
|
||
Enrolling by invitation |
NCT04322331 -
Tumor Immune Mechanism of Axillary Lymph Node Metastasis in Early Luminal Type A Breast Cancer
|
||
Recruiting |
NCT03868215 -
Use of Plasma ctDNA Methylation Haplotypes in Detecting Local Residual or Lymph Node Metastasis
|
||
Recruiting |
NCT04337333 -
Two-in-one Covered and Uncovered Metal Stent
|
N/A | |
Completed |
NCT04068636 -
Sentinel Node in Larynx and Pharynx Cancers
|
N/A | |
Recruiting |
NCT04671511 -
Targeted Axillary Dissection (TAD) in Early-stage Node Positive Breast Cancer
|
N/A |